AVXL

Anavex Life Sciences · USD

Market closed US (NYSE / Nasdaq) · 09:30–16:00 · Sun 22:00 · approx

Deep AI analysis (big model)

No deep analysis yet. Portfolio holdings are analysed automatically; for any other stock, click “Request deep AI analysis” above.

About Anavex Life Sciences

Anavex Life Sciences (AVXL) is a biopharmaceutical company focused on developing therapies for neurodegenerative diseases and cancer, but I am unable to recognize it as a publicly traded company with significant market presence.

Ticker	AVXL
Name	Anavex Life Sciences
Currency	USD

Reputation

🙂

How liked 50/100

From 0 recent analysed stories — 0 good · 0 bad · 0 neutral. Trend: stable.

Reputation builds as news about this company is analysed.

Price history & forecast

30-day forecast — Linear regression, Holt's exponential smoothing, and drift, plus a news-adjusted consensus (sentiment tilt +0.00). Estimates only, not advice.

Candlestick, volume & news sentiment

good bad neutral

Daily open/high/low/close candles with volume bars beneath; hover a candle for its OHLC, change and volume. Dots mark analysed news coloured by sentiment. Pick a range, or click-and-drag across the chart to zoom in.

Forecast accuracy (backtested)

No scored forecasts yet. Every visit records the day's forecast; once those predicted dates pass, this table fills in with how each method actually did (1 snapshot(s) recorded so far, none matured yet).

Technical analysis

BEARISH

41.93

RSI (14)i

2.82

SMA 20i

4.89

SMA 50i

5.29

SMA 200i

0.00%

1di

0.00%

1wi

-17.63%

1mi

13.55%

30d voli

22.86

52w highi

0.70

52w lowi

-88.76%

from highi

-0.62

MACDi

Downtrend (50d below 200d)MACD bullish crossover

Computed from 260 locally-stored price bars.

AI signals

HOLD 80% · long_term 2026-06-08 00:13

The stock has experienced a significant drop in value over the past few months, with no recent positive news or catalysts to suggest an imminent reversal. The current price is near its lowest point and shows little sign of improvement, which suggests caution. However, given that the stock has already reached a low level, there's also a possibility it could stabilize or even start to recover if market conditions improve.

qwen2.5:3b